138 related articles for article (PubMed ID: 27249794)
1. Expression of PAX8 Target Genes in Papillary Thyroid Carcinoma.
Rosignolo F; Sponziello M; Durante C; Puppin C; Mio C; Baldan F; Di Loreto C; Russo D; Filetti S; Damante G
PLoS One; 2016; 11(6):e0156658. PubMed ID: 27249794
[TBL] [Abstract][Full Text] [Related]
2. Gene expression of thyroid-specific transcription factors may help diagnose thyroid lesions but are not determinants of tumor progression.
Batista FA; Ward LS; Marcello MA; Martins MB; Peres KC; Torricelli C; Bufalo NE; Soares FA; da Silva MJ; Assumpção LV
J Endocrinol Invest; 2016 Apr; 39(4):423-9. PubMed ID: 26370671
[TBL] [Abstract][Full Text] [Related]
3. MYC promotes the development of papillary thyroid carcinoma by inhibiting the expression of lncRNA PAX8‑AS1:28.
Zhang Y; Li F; Chen J
Oncol Rep; 2019 Apr; 41(4):2511-2517. PubMed ID: 30720110
[TBL] [Abstract][Full Text] [Related]
4. GLIS Rearrangement is a Genomic Hallmark of Hyalinizing Trabecular Tumor of the Thyroid Gland.
Nikiforova MN; Nikitski AV; Panebianco F; Kaya C; Yip L; Williams M; Chiosea SI; Seethala RR; Roy S; Condello V; Santana-Santos L; Wald AI; Carty SE; Ferris RL; El-Naggar AK; Nikiforov YE
Thyroid; 2019 Feb; 29(2):161-173. PubMed ID: 30648929
[TBL] [Abstract][Full Text] [Related]
5. Key genes and pathways predicted in papillary thyroid carcinoma based on bioinformatics analysis.
Yu J; Mai W; Cui Y; Kong L
J Endocrinol Invest; 2016 Nov; 39(11):1285-1293. PubMed ID: 27250077
[TBL] [Abstract][Full Text] [Related]
6. Trisomy 17 as a marker for a subset of noninvasive thyroid nodules with focal features of papillary carcinoma: cytogenetic and molecular analysis of 62 cases and correlation with histological findings.
Frau DV; Lai ML; Caria P; Dettori T; Coni P; Faa G; Morandi L; Tallini G; Vanni R
J Clin Endocrinol Metab; 2008 Jan; 93(1):177-81. PubMed ID: 17956956
[TBL] [Abstract][Full Text] [Related]
7. Paired box gene 8, HBME-1, and cytokeratin 19 expression in preoperative fine-needle aspiration of papillary thyroid carcinoma: diagnostic utility.
Schmitt AC; Cohen C; Siddiqui MT
Cancer Cytopathol; 2010 Aug; 118(4):196-202. PubMed ID: 20731005
[TBL] [Abstract][Full Text] [Related]
8. Genetic alterations in thyroid tumors from patients irradiated in childhood for tinea capitis treatment.
Boaventura P; Pereira D; Celestino R; Mendes A; Nakasawa T; Teixeira-Gomes J; Sobrinho-Simões M; Soares P
Eur J Endocrinol; 2013 Nov; 169(5):673-9. PubMed ID: 23966419
[TBL] [Abstract][Full Text] [Related]
9. Expression of PAX8-PPAR gamma 1 rearrangements in both follicular thyroid carcinomas and adenomas.
Marques AR; Espadinha C; Catarino AL; Moniz S; Pereira T; Sobrinho LG; Leite V
J Clin Endocrinol Metab; 2002 Aug; 87(8):3947-52. PubMed ID: 12161538
[TBL] [Abstract][Full Text] [Related]
10. An epistatic interaction between the PAX8 and STK17B genes in papillary thyroid cancer susceptibility.
Landa I; Boullosa C; Inglada-Pérez L; Sastre-Perona A; Pastor S; Velázquez A; Mancikova V; Ruiz-Llorente S; Schiavi F; Marcos R; Malats N; Opocher G; Diaz-Uriarte R; Santisteban P; Valencia A; Robledo M
PLoS One; 2013; 8(9):e74765. PubMed ID: 24086368
[TBL] [Abstract][Full Text] [Related]
11. Thyrospheres From Normal or Malignant Thyroid Tissue Have Different Biological, Functional, and Genetic Features.
Gianì F; Vella V; Nicolosi ML; Fierabracci A; Lotta S; Malaguarnera R; Belfiore A; Vigneri R; Frasca F
J Clin Endocrinol Metab; 2015 Sep; 100(9):E1168-78. PubMed ID: 26151334
[TBL] [Abstract][Full Text] [Related]
12. BRAF mutations in papillary thyroid carcinomas inhibit genes involved in iodine metabolism.
Durante C; Puxeddu E; Ferretti E; Morisi R; Moretti S; Bruno R; Barbi F; Avenia N; Scipioni A; Verrienti A; Tosi E; Cavaliere A; Gulino A; Filetti S; Russo D
J Clin Endocrinol Metab; 2007 Jul; 92(7):2840-3. PubMed ID: 17488796
[TBL] [Abstract][Full Text] [Related]
13. Molecular profile and clinical-pathologic features of the follicular variant of papillary thyroid carcinoma. An unusually high prevalence of ras mutations.
Zhu Z; Gandhi M; Nikiforova MN; Fischer AH; Nikiforov YE
Am J Clin Pathol; 2003 Jul; 120(1):71-7. PubMed ID: 12866375
[TBL] [Abstract][Full Text] [Related]
14. Detection of the PAX8-PPAR gamma fusion oncogene in both follicular thyroid carcinomas and adenomas.
Cheung L; Messina M; Gill A; Clarkson A; Learoyd D; Delbridge L; Wentworth J; Philips J; Clifton-Bligh R; Robinson BG
J Clin Endocrinol Metab; 2003 Jan; 88(1):354-7. PubMed ID: 12519876
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic significance of PAX8 in thyroid squamous cell carcinoma.
Suzuki A; Hirokawa M; Takada N; Higuchi M; Yamao N; Kuma S; Daa T; Miyauchi A
Endocr J; 2015; 62(11):991-5. PubMed ID: 26354716
[TBL] [Abstract][Full Text] [Related]
16. Genome-wide expression analysis of Middle Eastern papillary thyroid cancer reveals c-MET as a novel target for cancer therapy.
Siraj AK; Bavi P; Abubaker J; Jehan Z; Sultana M; Al-Dayel F; Al-Nuaim A; Alzahrani A; Ahmed M; Al-Sanea O; Uddin S; Al-Kuraya KS
J Pathol; 2007 Oct; 213(2):190-9. PubMed ID: 17703498
[TBL] [Abstract][Full Text] [Related]
17. From nodule to differentiated thyroid carcinoma: contributions of molecular analysis in 2012.
Albarel F; Conte-Devolx B; Oliver C
Ann Endocrinol (Paris); 2012 Jun; 73(3):155-64. PubMed ID: 22503804
[TBL] [Abstract][Full Text] [Related]
18. The expression and role of serum response factor in papillary carcinoma of the thyroid.
Kim HJ; Kim KR; Park HS; Jang KY; Chung MJ; Shong M; Moon WS
Int J Oncol; 2009 Jul; 35(1):49-55. PubMed ID: 19513551
[TBL] [Abstract][Full Text] [Related]
19. BRAFV600E mutation, but not RET/PTC rearrangements, is correlated with a lower expression of both thyroperoxidase and sodium iodide symporter genes in papillary thyroid cancer.
Romei C; Ciampi R; Faviana P; Agate L; Molinaro E; Bottici V; Basolo F; Miccoli P; Pacini F; Pinchera A; Elisei R
Endocr Relat Cancer; 2008 Jun; 15(2):511-20. PubMed ID: 18509003
[TBL] [Abstract][Full Text] [Related]
20. All-trans-retinoic acid modulates expression levels of thyroglobulin and cytokines in a new human poorly differentiated papillary thyroid carcinoma cell line, KTC-1.
Kurebayashi J; Tanaka K; Otsuki T; Moriya T; Kunisue H; Uno M; Sonoo H
J Clin Endocrinol Metab; 2000 Aug; 85(8):2889-96. PubMed ID: 10946899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]